Study
Alkermes Presents Detailed Positive Results From Vibrance-2 Phase 2 Study of Alixorexton in Adults With Narcolepsy Type 2 at SLEEP 2026
Wednesday 17 June 2026 10:02 pm | Updated: Wednesday 17 June 2026 10:03 pm Alkermes plc (Nasdaq: ALKS) today announced detailed positive results from the Vibrance-2 phase 2 dose-ranging study evaluating alixorexton in patients with narcolepsy type 2 (NT2). Once-daily alixorexton met the study’s dual primary endpoints, demonstrating statistically significant and clinically meaningful improvements from baseline […]
This Is Why You Should Study In Denmark
Source: studyabroadguide.com When you start exploring your options for studying abroad, you would most likely discover Denmark as among some of the perfect destinations to embark on your academic journey. You would also discover the wonders of this wonderful country, and experience the epitome of academic excellence, advanced technologies, and a populace brimming with intellectual […]